Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
初级保健中的成瘾远程医疗咨询:增加酒精问题药物治疗和专业治疗的机会
基本信息
- 批准号:10212895
- 负责人:
- 金额:$ 69.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-10 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAdoptionAdultAffectAlcohol abuseAlcohol consumptionCaringCharacteristicsClinicClinical PharmacistsCluster randomized trialConsultConsultationsDataDisulfiramDrug PrescriptionsEffectivenessElectronic Health RecordElectronic MailElementsFeasibility StudiesFeedbackFormulationFrequenciesHealth Care CostsHealth PersonnelHealth systemHealthcare SystemsHeavy DrinkingInjectableInterventionInterviewLiteratureLogisticsMedicalMedicineModelingMorbidity - disease rateNaltrexoneOralPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacotherapyPilot ProjectsPrimary Care PhysicianPrimary Health CareProviderPublic HealthRaceResearchRouteServicesStructureTechniquesTelemedicineTelephoneTimeTrainingTraining and EducationVisitacamprosateaddictionalcohol abuse therapyalcohol misusealcohol screening and brief interventionalcohol use disorderarmbasecare providerscare systemsclinical carecontinuing medical educationcostdesigndrinkingethnic disparityevidence baseflexibilityfollow-upgender disparityhealth service useimplementation barriersimplementation outcomesimprovedinnovationinpatient serviceinsightmedical specialtiesmortalitymotivational enhancement therapymulti-component interventionpatient populationprimary care settingprogramspublic health relevanceroutine carescreening, brief intervention, referral, and treatmentservice utilizationsocioeconomicstooltreatment armtreatment as usualurgent careusual care arm
项目摘要
ABSTRACT
Alcohol use disorders (AUDs) are a major public health problem and pose significant challenges to
clinicians, patients, and health systems. AUDs are associated with serious medical conditions, can complicate
medical treatment and increase avoidable health service utilization and costs. Yet most patients who would
benefit from evidence-based AUD treatment, including pharmacotherapy, do not receive these services.
Although medications such as naltrexone, acamprosate and disulfiram can be effective for moderate to severe
alcohol problems, primary care providers (PCPs) are often reluctant to prescribe, and AUD medications remain
underused. Innovative care models are needed to give PCPs the tools they need to address AUDs in primary
care settings, but few studies have examined interventions to improve AUD medication delivery and specialty
care initiation. To address this substantial gap in the evidence base, this pragmatic, cluster-randomized trial in
adult primary care clinics (n=20) in a large, ethnically and socioeconomically diverse healthcare system, will
examine the effectiveness of an innovative, multi-faceted intervention: the Addiction Telemedicine Consultant
service, or “ATC.” The ATC provides a flexible, efficient, centralized approach to bringing Addiction Medicine
expertise directly into primary care. PCPs can access the ATC via three routes: real-time video or telephone
connection during primary care visits, asynchronous email, and telephone consultation. The ATC, a clinical
pharmacist, may assess the patient, discuss appropriate AUD medications with the PCP and patient, and if
appropriate, guide the PCP through prescribing logistics, or initiate the prescription themselves. The
motivational interviewing-trained ATC may also encourage the patient to initiate specialty addiction treatment
and facilitate connection to a local program. The ATC intervention will also offer initial continuing medical
education training on AUDs and AUD medication prescribing, and ongoing technical assistance, to all PCPs in
the ATC arm. We will compare the ATC arm to Usual Care, which includes routine alcohol screening, brief
intervention and referral to treatment (SBIRT) in primary care. We conducted a pilot feasibility study of the
ATC model, and the proposed trial builds on our pilot findings, the extant literature, and incorporates
stakeholder feedback in its design. We will use electronic health record data captured during the course of
regular clinical care to examine treatment arm effects on implementation outcomes (AUD medication
prescription rates and addiction treatment referral rates) and patient outcomes (AUD medication fill rates,
addiction treatment initiation, alcohol use (drinking days/week, # drinks/week, # of “heavy” drinking days
(4+/5+/day) in past 90 days), and health services utilization and costs, over two years. If the intervention is
effective, this study has the capacity to spur the use of safe, effective pharmacotherapy for AUDs as a standard
practice in primary care settings and profoundly affect how we treat and study the full spectrum of alcohol use
problems.
摘要
酒精使用障碍(AUDs)是一个主要的公共卫生问题,并构成重大挑战,
临床医生、患者和卫生系统。AUD与严重的医疗状况有关,可能使
医疗和增加可避免的卫生服务利用和成本。然而,大多数患者
受益于循证AUD治疗(包括药物治疗)的患者不接受这些服务。
尽管纳洛酮、阿坎酸和双硫仑等药物对中度至重度的糖尿病患者有效,
酒精问题,初级保健提供者(PCP)往往不愿意开药,AUD药物仍然存在
未充分利用需要创新的护理模式,为PCP提供解决小学AUD所需的工具
护理环境,但很少有研究检查干预措施,以改善AUD药物输送和专业
护理启动。为了解决证据基础中的这一实质性差距,这项务实的,随机分组试验,
在一个大型的、种族和社会经济多样化的医疗保健系统中,成人初级保健诊所(n=20)将
检查一个创新的,多方面的干预的有效性:成瘾远程医疗顾问
服务,或“ATC”。ATC提供了一种灵活、高效、集中的方法,
专业知识直接进入初级保健。PCP可以通过三种途径访问ATC:实时视频或电话
初级保健访问期间的连接,异步电子邮件和电话咨询。ATC,临床
药剂师可以评估患者,与PCP和患者讨论适当的AUD药物,如果
适当时,通过处方物流指导PCP,或自己开处方。的
经过动机访谈训练的ATC也可以鼓励患者开始专业成瘾治疗
并便于连接到本地程序。ATC干预还将提供初步的持续医疗服务,
向所有PCP提供关于AUD和AUD药物处方的教育培训,以及持续的技术援助,
ATC臂。我们将比较ATC臂的日常护理,其中包括常规酒精筛查,简要
干预和转诊治疗(SBIRT)。我们进行了一项可行性试验研究,
ATC模型,拟议的试验建立在我们的试点结果,现存的文献,并结合
利益攸关方在其设计中的反馈意见。我们将使用在以下过程中捕获的电子健康记录数据
定期临床护理,以检查治疗组对实施结局的影响(AUD药物
处方率和成瘾治疗转诊率)和患者结局(澳元药物填充率,
成瘾治疗开始、酒精使用(饮酒天数/周、饮酒次数/周、“重度”饮酒天数
(过去90天4+/5+/天)以及两年的保健服务利用率和费用。如果干预是
有效,这项研究有能力刺激使用安全,有效的药物治疗AUDs作为标准
在初级保健环境中的实践,并深刻影响我们如何治疗和研究酒精使用的全方位
问题
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stacy Ann Sterling其他文献
Stacy Ann Sterling的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stacy Ann Sterling', 18)}}的其他基金
Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use via Telehealth
儿科初级保健虚拟 SBIRT:通过远程医疗增加酒精和其他药物使用筛查、简短干预和转诊治疗的机会
- 批准号:
10706560 - 财政年份:2022
- 资助金额:
$ 69.84万 - 项目类别:
Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use via Telehealth
儿科初级保健虚拟 SBIRT:通过远程医疗增加酒精和其他药物使用筛查、简短干预和转诊治疗的机会
- 批准号:
10606351 - 财政年份:2022
- 资助金额:
$ 69.84万 - 项目类别:
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
初级保健中的成瘾远程医疗咨询:增加酒精问题药物治疗和专业治疗的机会
- 批准号:
10616496 - 财政年份:2020
- 资助金额:
$ 69.84万 - 项目类别:
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
初级保健中的成瘾远程医疗咨询:增加酒精问题药物治疗和专业治疗的机会
- 批准号:
10397099 - 财政年份:2020
- 资助金额:
$ 69.84万 - 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
- 批准号:
10264654 - 财政年份:2019
- 资助金额:
$ 69.84万 - 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
- 批准号:
10413909 - 财政年份:2019
- 资助金额:
$ 69.84万 - 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
- 批准号:
10172807 - 财政年份:2019
- 资助金额:
$ 69.84万 - 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
- 批准号:
10414232 - 财政年份:2019
- 资助金额:
$ 69.84万 - 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
- 批准号:
10630316 - 财政年份:2019
- 资助金额:
$ 69.84万 - 项目类别:
Population-based Screening and Brief Intervention in Primary Care: Health and Drinking Outcomes, Cost and Utilization
初级保健中基于人群的筛查和短期干预:健康和饮酒结果、成本和利用
- 批准号:
9355066 - 财政年份:2017
- 资助金额:
$ 69.84万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 69.84万 - 项目类别:
Research Grant